Corteva completed a spin-off of its advanced seed business earlier this month.
JPMorgan revisited its rating on Corteva stock.
Corteva reports third-quarter 2026 financial results in November.
Starting the week on a positive note, Corteva (NYSE:CTVA) stock rose 4% yesterday, outperforming the S&P 500's 0.7% gain. And the market's appetite for agricultural stocks continues today, thanks to an analyst’s bullish outlook on Corteva.
As of 1:40 p.m. ET, Corteva shares are up 12.2%.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Upgrading it from neutral to overweight, JPMorgan assigned a $19 price target to Corteva stock today. Based on yesterday's closing price of $12.39, the $19 price target implies 53.3% upside.
According to Thefly.com, JPMorgan took the bullish stance on Corteva stock, believing that it's now undervalued following the Oct. 1 spinoff of the company's advanced seed and genetics business.
Building on several years of success in its crop protection business, Corteva believes it's well-positioned for future growth, now that it's no longer focused on the advanced seed and genetics business. From 2020 through 2025, for example, Corteva's crop protection business grew sales by over $1 billion while expanding segment-level operating earnings before interest, taxes, depreciation, and amortization (EBITDA) margins by about 250 basis points.
While JPMorgan believes that Corteva stock has ample room to run, prospective investors should take this outlook with a grain of salt, remembering that this is merely one firm's opinion -- not a guarantee that the stock will, in fact, soar. A better course of action at this point is to check in on what the company said in early November, when it reports third-quarter 2026 financial results, to see how things are proceeding following the spinoff of the advanced seed business. In the meantime, there are plenty of other agriculture stocks to consider.
Before you buy stock in Corteva, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Corteva wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $364,023!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,467,933!*
Now, it’s worth noting Stock Advisor’s total average return is 948% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of October 6, 2026.
JPMorgan Chase is an advertising partner of Motley Fool Money. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends JPMorgan Chase. The Motley Fool has a disclosure policy.